We wanted to reassure you that Arizona Oncology remains open to provide medically necessary, life-sustaining care. In addition, our expert care team can now see patients through scheduled virtual appointments on a secure platform from the comfort and safety of your home.

Please note; only one caregiver is allowed to accompany during your appointment, no one under the age of 18, and no visitors in the infusion rooms, radiation and treatment areas. If you have flu-like symptoms, you should contact Arizona Oncology before visiting our clinics for scheduled appointments. This includes fever and symptoms of respiratory illness, such as coughing or difficulty breathing.
We ask that you follow our tips to stay healthy and to help do our part in prevention of spreading of these viruses.

Locations and Physicians

Raymond Taetle, MD

Patient Portal


Medical Oncology & Hematology


Tucson - Wilmot Road
603 N. Wilmot Road, Suite 151
Tucson, AZ 85711
Phone: (520) 886-0206
Fax: (520) 886-0829

Raymond Taetle, MD


University of Michigan

Medical School

Northwestern University


University of California-San Diego


University of California-San Diego


Hematology and Oncology - Department of Medicine at University of California-San Diego

Board Certification

Dr. Taetle is board certified in Hematology and Medical Oncology.


Dr. Taetle has earned many honors including an MD with distinction and memberships in Phi Eta Sigma; Phi Beta Kappa; Phi Kappa Phi; Phi Kappa Phi Award for Outstanding Academic Achievement; George B. Angell Scholar; Alpha Omega Alpha; president of the Interns and Residents Association, University of California, San Diego; and Fellow, American College of Physicians.

He is a member of American Society of Clinical Oncology, American Society of Hematology, the Arizona Clinical Oncology Society, Southwest Oncology Group, Pima County Medical Society and American College of Physicians, and serves as an associate affiliate physician for Children's Clinics for Rehabilitative Services.

He has served as an advisor to the National Cancer Institute and on its Experimental Therapeutics Study Section; as an advisor to the American Cancer Society; and on the editorial boards of several journals. Dr. Taetle holds several U.S. patents, including: No. 5,439,936, lIIudinAnalogs Useful as Antitumor Agents; No. 5,439,942, Method of Treating Certain Tumors Using lIIudinAnalogs; No. 5,523,490, lIIudinAnalogs; No. 5,563,176, lIIudinAnalogs Useful as Anti-tumor Agents; and European Patent No. 0565519, lIIudinAnalogs as Anti-tumor Agents. He is also widely published in a variety of peer-reviewed and other medical journals.



In The Media

Congratulations to Arizona Oncology’s TOP DOCS